miR-497 and 219 in blood aid meningioma classification

Zhao L, Zhao W, Hou Y, Wen C, Wang J, Wu P, Guo Z (2020) An overview of managements in meningiomas. Front Oncol 10:1523. https://doi.org/10.3389/fonc.2020.01523

Article  PubMed  PubMed Central  Google Scholar 

Goldbrunner R, Stavrinou P, Jenkinson MD, Sahm F, Mawrin C, Weber DC, Preusser M, Minniti G, Lund-Johansen M, Lefranc F et al (2021) EANO guideline on the diagnosis and management of meningiomas. Neuro-oncology 23:1821–1834. https://doi.org/10.1093/neuonc/noab150

CAS  Article  PubMed  PubMed Central  Google Scholar 

Goldbrunner R, Minniti G, Preusser M, Jenkinson MD, Sallabanda K, Houdart E, von Deimling A, Stavrinou P, Lefranc F, Lund-Johansen M et al (2016) EANO guidelines for the diagnosis and treatment of meningiomas. Lancet Oncol 17:e383–e391. https://doi.org/10.1016/s1470-2045(16)30321-7

Article  PubMed  Google Scholar 

Islim AI, Mohan M, Moon RDC, Srikandarajah N, Mills SJ, Brodbelt AR, Jenkinson MD (2019) Incidental intracranial meningiomas: a systematic review and meta-analysis of prognostic factors and outcomes. J Neurooncol 142:211–221. https://doi.org/10.1007/s11060-019-03104-3

CAS  Article  PubMed  PubMed Central  Google Scholar 

Nassiri F, Mamatjan Y, Suppiah S, Badhiwala JH, Mansouri S, Karimi S, Saarela O, Poisson L, Gepfner-Tuma I, Schittenhelm J et al (2019) DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management. Neuro-oncology 21:901–910. https://doi.org/10.1093/neuonc/noz061

CAS  Article  PubMed  PubMed Central  Google Scholar 

Sahm F, Schrimpf D, Stichel D, Jones DTW, Hielscher T, Schefzyk S, Okonechnikov K, Koelsche C, Reuss DE, Capper D et al (2017) DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol 18:682–694. https://doi.org/10.1016/S1470-2045(17)30155-9

CAS  Article  PubMed  Google Scholar 

Euskirchen P, Peyre M (2018) Management of meningioma. La Presse Médicale 47:e245–e252. https://doi.org/10.1016/j.lpm.2018.05.016

Article  PubMed  Google Scholar 

Cui M, Wang H, Yao X, Zhang D, Xie Y, Cui R, Zhang X (2019) Circulating microRNAs in cancer: potential and challenge. Front Genet 10:626

CAS  Article  Google Scholar 

Esquela-Kerscher A, Slack FJ (2006) Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer 6:259–269. https://doi.org/10.1038/nrc1840

CAS  Article  PubMed  Google Scholar 

Chen X, Liang H, Zen K, Zhang C-Y (2016) Secreted microRNAs from tumor cells can suppress immune function. Oncoimmunology 5:e982407

Article  Google Scholar 

Chen X, Liang H, Zhang J, Zen K, Zhang C-Y (2012) Secreted microRNAs: a new form of intercellular communication. Trends Cell Biol 22:125–132

CAS  Article  Google Scholar 

Rosenfeld N, Aharonov R, Meiri E, Rosenwald S, Spector Y, Zepeniuk M, Benjamin H, Shabes N, Tabak S, Levy A (2008) MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol 26:462

CAS  Article  Google Scholar 

Nik Mohamed Kamal NNSB, Shahidan WNS (2020) Non-exosomal and exosomal circulatory microRNAs: which are more valid as biomarkers? Front Pharmacol 10:1500

Article  Google Scholar 

Yang G, Xiong G, Cao Z, Zheng S, You L, Zhang T, Zhao Y (2016) miR-497 expression, function and clinical application in cancer. Oncotarget 7:55900–55911. https://doi.org/10.18632/oncotarget.10152

Article  PubMed  PubMed Central  Google Scholar 

Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, Zeng YX, Shao JY (2008) MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14:2348–2360. https://doi.org/10.1261/rna.1034808

CAS  Article  PubMed  PubMed Central  Google Scholar 

Liu Z, Wu S, Wang L, Kang S, Zhao B, He F, Liu X, Zeng Y, Liu J (2019) Prognostic value of microRNA-497 in various cancers: a systematic review and meta-analysis. Dis mark 2019:2491291–2491291. https://doi.org/10.1155/2019/2491291

CAS  Article  Google Scholar 

Özata DM, Caramuta S, Velázquez-Fernández D, Akçakaya P, Xie H, Höög A, Zedenius J, Bäckdahl M, Larsson C, Lui W-O (2011) The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma. Endocr Relat Cancer 18:643–655. https://doi.org/10.1530/ERC-11-0082

CAS  Article  PubMed  PubMed Central  Google Scholar 

Xu J-W, Wang T-X, You L, Zheng L-F, Shu H, Zhang T-P, Zhao Y-P (2014) Insulin-like growth factor 1 receptor (IGF-1R) as a target of miR-497 and plasma IGF-1R levels associated with TNM stage of pancreatic cancer. PLoS ONE 9:e92847. https://doi.org/10.1371/journal.pone.0092847

CAS  Article  PubMed  PubMed Central  Google Scholar 

Itesako T, Seki N, Yoshino H, Chiyomaru T, Yamasaki T, Hidaka H, Yonezawa T, Nohata N, Kinoshita T, Nakagawa M et al (2014) The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster. PLoS ONE 9:e84311. https://doi.org/10.1371/journal.pone.0084311

CAS  Article  PubMed  PubMed Central  Google Scholar 

Wang S, Mo Y, Midorikawa K, Zhang Z, Huang G, Ma N, Zhao W, Hiraku Y, Oikawa S, Murata M (2015) The potent tumor suppressor miR-497 inhibits cancer phenotypes in nasopharyngeal carcinoma by targeting ANLN and HSPA4L. Oncotarget 6(2015):35893–35907. https://doi.org/10.18632/oncotarget.5651

Article  PubMed  PubMed Central  Google Scholar 

Shen L, Li J, Xu L, Ma J, Li H, Xiao X, Zhao J, Fang L (2012) miR-497 induces apoptosis of breast cancer cells by targeting Bcl-w. Exp Ther Med 3:475–480. https://doi.org/10.3892/etm.2011.428

CAS  Article  PubMed  Google Scholar 

Li W, Jin X, Deng X, Zhang G, Zhang B, Ma L (2014) The putative tumor suppressor microRNA-497 modulates gastric cancer cell proliferation and invasion by repressing eIF4E. Biochem Biophys Res Commun 449:235–240. https://doi.org/10.1016/j.bbrc.2014.05.011

CAS  Article  PubMed  Google Scholar 

Yan J-J, Zhang Y-N, Liao J-Z, Ke K-P, Chang Y, Li P-Y, Wang M, Lin J-S, He X-X (2015) miR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1. Oncotarget 6:29527–29542. https://doi.org/10.18632/oncotarget.5012

Article  PubMed  PubMed Central  Google Scholar 

Wang W, Ren F, Wu Q, Jiang D, Li H, Shi H (2014) MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the Pi3k/Akt and MAPK/ERK pathways in ovarian cancer. Oncol Rep 32:2127–2133. https://doi.org/10.3892/or.2014.3439

CAS  Article  PubMed  Google Scholar 

Wei C, Luo Q, Sun X, Li D, Song H, Li X, Song J, Hua K, Fang L (2015) MicroRNA-497 induces cell apoptosis by negatively regulating Bcl-2 protein expression at the posttranscriptional level in human breast cancer. Int J Clin Exp Pathol 8:7729–7739

CAS  PubMed  PubMed Central  Google Scholar 

Wang L, Li B, Li L, Wang T (2013) MicroRNA-497 suppresses proliferation and induces apoptosis in prostate cancer cells. Asian Pac J Cancer Prev 14:3499–3502. https://doi.org/10.7314/apjcp.2013.14.6.3499

Article  PubMed  Google Scholar 

Teplyuk NM, Mollenhauer B, Gabriely G, Giese A, Kim E, Smolsky M, Kim RY, Saria MG, Pastorino S, Kesari S (2012) MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity. Neuro-oncology 14:689–700

CAS  Article  Google Scholar 

López-Aguilar JE, Velázquez-Flores MA, Simón-Martínez LA, Ávila-Miranda R, Rodríguez-Florido MA, Garrido RR-E (2017) Circulating microRNAs as biomarkers for pediatric astrocytomas. Arch Med Res 48:323–332

Article  Google Scholar 

Yue X, Lan F, Hu M, Pan Q, Wang Q, Wang J (2016) Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma. J Neurosurg 124:122–128

CAS  Article  Google Scholar 

Regazzo G, Terrenato I, Spagnuolo M, Carosi M, Cognetti G, Cicchillitti L, Sperati F, Villani V, Carapella C, Piaggio G et al (2016) A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas. J Exp Clin Cancer Res 35:124. https://doi.org/10.1186/s13046-016-0393-0

CAS  Article  PubMed  PubMed Central  Google Scholar 

Negroni C, Hilton DA, Ercolano E, Adams CL, Kurian KM, Baiz D, Hanemann CO (2020) GATA-4, a potential novel therapeutic target for high-grade meningioma, regulates miR-497, a potential novel circulating biomarker for high-grade meningioma. EBioMedicine 59:102941. https://doi.org/10.1016/j.ebiom.2020.102941

CAS  Article  PubMed  PubMed Central  Google Scholar 

Zhi F, Shao N, Li B, Xue L, Deng D, Xu Y, Lan Q, Peng Y, Yang Y (2016) A serum 6-miRNA panel as a novel non-invasive biomarker for meningioma. Sci Rep 6:32067. https://doi.org/10.1038/srep32067

CAS  Article  PubMed  PubMed Central  Google Scholar 

Schageman J, Zeringer E, Li M, Barta T, Lea K, Gu J, Magdaleno S, Setterquist R, Vlassov AV (2013) The complete exosome workflow solution: from isolation to characterization of RNA cargo. Biomed Res Int 2013:253957. https://doi.org/10.1155/2013/253957

CAS  Article  PubMed  PubMed Central  Google Scholar 

Adams CL, Ercolano E, Ferluga S, Sofela A, Dave F, Negroni C, Kurian KM, Hilton DA, Hanemann CO (2020) A rapid robust method for subgrouping non-NF2 meningiomas according to genotype and detection of lower levels of M2 macrophages in AKT1 E17K mutated tumours. Int J Mol Sci. https://doi.org/10.3390/ijms21041273

Article  PubMed  PubMed Central  Google Scholar 

Madadi S, Soleimani M (2019) Comparison of miR-16 and cel-miR-39 as reference controls for serum miRNA normalization in colorectal cancer. J Cell Biochem 120:4802–4803. https://doi.org/10.1002/jcb.28174

CAS  Article  PubMed  Google Scholar 

Wang L, Chen S, Liu Y, Zhang H, Ren N, Ma R, He Z (2020) The biological and diagnos

留言 (0)

沒有登入
gif